SCHEMBL6544895

SCHEMBL6544895

CC(C)(C)[Si](C)(C)O[C@@H]1CCN(c2ccc(N)cc2F)C1

nearest known ligand 0.46

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
GFER P55789 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
ACACB O00763 12/20 0.39
HTT P42858 1/20 0.36
LIPG Q9Y5X9 5/20 0.36
LIPC P11150 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7805636 1.00 ALDH1A1 (0.41) ALDH1A1LMNAMAPTMAPK1GFER
SCHEMBL25261185 0.93 ALDH1A1 (0.46) ALDH1A1LMNAMAPTMAPK1GFER
SCHEMBL7814936 0.81 ALDH1A1 (0.48) ALDH1A1LMNAMAPTTDP1HTT
SCHEMBL7078416 0.81 ALDH1A1 (0.48) ALDH1A1LMNAMAPTTDP1HTT
SCHEMBL31480867 0.81 ALDH1A1 (0.48) ALDH1A1LMNAMAPTMAPK1GFER
SCHEMBL25243349 0.80 MAPT (0.38) ALDH1A1LMNAMAPTMAPK1GFER
SCHEMBL25243350 0.80 MAPT (0.38) ALDH1A1LMNAMAPTMAPK1GFER
SCHEMBL7956455 0.80 ROCK2 (0.37) ACACBLIPG
SCHEMBL7807712 0.77 CALML3 (0.51) LMNA
SCHEMBL7807715 0.77 CALML3 (0.51) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040060127-A1 Composition for dyeing keratin fibers, comprising at least one para-phenylenediamine derivative comprising a pyrrolidyl group substituted with a silyl radical L'OREAL S.A. (FR) 2004-04-01 US claimed
EP-1375480-A1 Para-phenylene-diamine derivatives comprising a silyl substituted pyrrolidine group and their use for the colouring of keratinic fibres L'OREAL (FR) 2004-01-02 EP claimed
US-20040060127-A1 Composition for dyeing keratin fibers, comprising at least one para-phenylenediamine derivative comprising a pyrrolidyl group substituted with a silyl radical L'OREAL S.A. (FR) 2004-04-01 US disclosed
EP-1375480-A1 Para-phenylene-diamine derivatives comprising a silyl substituted pyrrolidine group and their use for the colouring of keratinic fibres L'OREAL (FR) 2004-01-02 EP disclosed
EP-1375480-A1 Para-phenylene-diamine derivatives comprising a silyl substituted pyrrolidine group and their use for the colouring of keratinic fibres L'OREAL (FR) 2004-01-02 EP disclosed
US-6617339-B1 5-Isoxazolyloxymethyl-3-((dihydroxypropanoyl)-4-tetrahydropyri dyl-3,5- difluorophenyl)oxazolidinone, or the phosphated derivative or its disodium salt; antibiotic with useful activity against Grampositive pathogens SYNGENTA LIMITED (GB) 2003-09-09 US disclosed
US-20030144263-A1 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them SYNGENTA LIMITED (GB) 2003-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040060127-A1 Composition for dyeing keratin fibers, comprising at least one para-phenylenediamine derivative comprising a pyrrolidyl group substituted with a silyl radical KRT18, VIM, CDC73 ALDH1A1 785/4885LMNA 188/4885MAPT 1037/4885
US-20030144263-A1 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them CYP3A5, CYP2D6, OXA1L ALDH1A1 3134/4885LMNA 3058/4885MAPT 4796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.